Literature DB >> 6714441

Pharmacoanthropology: drug metabolism.

W Kalow.   

Abstract

This is a report of similarities and differences among various ethnically defined populations with respect to their capacities to metabolize the prototype drugs antipyrine, caffeine, and debrisoquine. There were equal levels of the three main metabolites of antipyrine in the urine of Caucasians and Orientals; differences in antipyrine clearance between English and Indian subjects appeared to have environmental causes. Exploration of various metabolite ratios of caffeine in the urine of Caucasians and Orientals living in Canada showed three patterns: 1) no interethnic difference occurred in the ratio thought to indicate xanthine oxidase activity; 2) products of 7-demethylation and of hydroxylation of paraxanthine , both probably produced by cytochrome P-450, showed different averages in the populations; 3) the new secondary metabolite acetylformyl -methyluracil proved to be a useful indicator of the genetically controlled acetylator status, thereby confirming the well-known population difference for acetylator gene frequency. Analysis of data on debriosquine hydroxylation suggested that interpretation of the standardized metabolic ratio may be appropriate for Caucasian and Oriental groups but is misleading for published data from Saudi Arabia, Nigeria, and Ghana; even these two closely related West African populations seem to differ in debrisoquine metabolism.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6714441

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  7 in total

Review 1.  Ethnic differences in drug disposition and responsiveness.

Authors:  A J Wood; H H Zhou
Journal:  Clin Pharmacokinet       Date:  1991-05       Impact factor: 6.447

Review 2.  From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions.

Authors:  Daniel W Nebert; Ge Zhang; Elliot S Vesell
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

Review 3.  Pharmacogenetic perspectives on susceptibility to toxic industrial chemicals.

Authors:  E S Vesell
Journal:  Br J Ind Med       Date:  1987-08

4.  Unimodal distribution of the metabolic ratio for debrisoquine in Cuna Amerindians of Panama.

Authors:  L F Jorge; T D Arias; T Inaba; P R Jackson
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

5.  Debrisoquine oxidation polymorphism in a Tasmanian population.

Authors:  M E Veronese; S McLean
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

6.  A comparison of the pharmacokinetics of codeine and its metabolites in healthy Chinese and Caucasian extensive hydroxylators of debrisoquine.

Authors:  Q Y Yue; J O Svensson; F Sjöqvist; J Säwe
Journal:  Br J Clin Pharmacol       Date:  1991-06       Impact factor: 4.335

7.  A simple borohydride/GC method for measuring sparteine metabolites in man.

Authors:  T Inaba; A Vinks; S V Otton
Journal:  Br J Clin Pharmacol       Date:  1986-05       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.